These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 10420094

  • 1. Brain potentials and attention after acute and subchronic intranasal administration ofACTH 4-10 and desacetyl-alpha-MSH in humans.
    Smolnik R, Mölle M, Fehm HL, Born J.
    Neuroendocrinology; 1999 Jul; 70(1):63-72. PubMed ID: 10420094
    [Abstract] [Full Text] [Related]

  • 2. Event-related brain potentials and working memory function in healthy humans after single-dose and prolonged intranasal administration of adrenocorticotropin 4-10 and desacetyl-alpha-melanocyte stimulating hormone.
    Smolnik R, Perras B, Molle M, Fehm HL, Born J.
    J Clin Psychopharmacol; 2000 Aug; 20(4):445-54. PubMed ID: 10917406
    [Abstract] [Full Text] [Related]

  • 3. The melanocortin melanocyte-stimulating hormone/adrenocorticotropin(4-10) decreases body fat in humans.
    Fehm HL, Smolnik R, Kern W, McGregor GP, Bickel U, Born J.
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1144-8. PubMed ID: 11238499
    [Abstract] [Full Text] [Related]

  • 4. Intranasal application of the melanocortin 4 receptor agonist MSH/ACTH(4-10) in humans causes lipolysis in white adipose tissue.
    Wellhöner P, Hörster R, Jacobs F, Sayk F, Lehnert H, Dodt C.
    Int J Obes (Lond); 2012 May; 36(5):703-8. PubMed ID: 21629206
    [Abstract] [Full Text] [Related]

  • 5. Time course of ACTH 4-10 effects on human attention.
    Born J, Unseld U, Pietrowsky R, Bickel U, Voigt K, Fehm HL.
    Neuroendocrinology; 1990 Aug; 52(2):169-74. PubMed ID: 2177158
    [Abstract] [Full Text] [Related]

  • 6. Different cardiovascular profiles of three melanocortins in conscious rats; evidence for antagonism between gamma 2-MSH and ACTH-(1-24).
    Van Bergen P, Kleijne JA, De Wildt DJ, Versteeg DH.
    Br J Pharmacol; 1997 Apr; 120(8):1561-7. PubMed ID: 9113379
    [Abstract] [Full Text] [Related]

  • 7. Dose-dependent influences on electrophysiological signs of attention in humans after neuropeptide ACTH 4-10.
    Born J, Bräuninger W, Fehm-Wolfsdorf G, Voigt KH, Pauschinger P, Fehm HL.
    Exp Brain Res; 1987 Apr; 67(1):85-92. PubMed ID: 3040455
    [Abstract] [Full Text] [Related]

  • 8. Brain evoked responses, a bioassay for central actions of adrenocorticotropin (ACTH 1-39) and corticotropin releasing hormone (CRH) in humans.
    Born J, Seidel E, Pietrowsky R, Fehm HL.
    Horm Metab Res; 1991 Mar; 23(3):126-30. PubMed ID: 1650750
    [Abstract] [Full Text] [Related]

  • 9. Agouti antagonism of melanocortin-4 receptor: greater effect with desacetyl-alpha-melanocyte-stimulating hormone (MSH) than with alpha-MSH.
    Mountjoy KG, Willard DH, Wilkison WO.
    Endocrinology; 1999 May; 140(5):2167-72. PubMed ID: 10218968
    [Abstract] [Full Text] [Related]

  • 10. Synchronism of pressor response and grooming behavior in freely moving, conscious rats following intracerebroventricular administration of ACTH/MSH-like peptides.
    Versteeg DH, Florijn WJ, Holtmaat AJ, Gispen WH, De Wildt DJ.
    Brain Res; 1993 Dec 24; 631(2):265-9. PubMed ID: 8131054
    [Abstract] [Full Text] [Related]

  • 11. Fragments of ACTH affect electrophysiological signs of controlled stimulus processing in humans.
    Born J, Kern W, Pietrowsky R, Sittig W, Fehm HL.
    Psychopharmacology (Berl); 1989 Dec 24; 99(4):439-44. PubMed ID: 2556725
    [Abstract] [Full Text] [Related]

  • 12. Influences of ACTH 4-10 on event-related potentials reflecting attention in man.
    Born J, Fehm-Wolfsdorf G, Voigt KH, Fehm HL.
    Physiol Behav; 1987 Dec 24; 39(1):83-7. PubMed ID: 3031714
    [Abstract] [Full Text] [Related]

  • 13. Overweight humans are resistant to the weight-reducing effects of melanocortin4-10.
    Hallschmid M, Smolnik R, McGregor G, Born J, Fehm HL.
    J Clin Endocrinol Metab; 2006 Feb 24; 91(2):522-5. PubMed ID: 16317061
    [Abstract] [Full Text] [Related]

  • 14. An ACTH 4-9 analog impairs selective attention in man.
    Born J, Fehm-Wolfsdorf G, Schiebe M, Birbaumer N, Fehm HL, Voigt KH.
    Life Sci; 1985 Jun 03; 36(22):2117-25. PubMed ID: 2987636
    [Abstract] [Full Text] [Related]

  • 15. Brain potential changes after intranasal vs. intravenous administration of vasopressin: evidence for a direct nose-brain pathway for peptide effects in humans.
    Pietrowsky R, Strüben C, Mölle M, Fehm HL, Born J.
    Biol Psychiatry; 1996 Mar 01; 39(5):332-40. PubMed ID: 8704064
    [Abstract] [Full Text] [Related]

  • 16. Actions of desacetyl-alpha-melanocyte-stimulating hormone on human adrenocortical cells.
    Henville KL, Hinson JP, Vinson GP, Laird SM.
    J Endocrinol; 1989 Jun 01; 121(3):579-83. PubMed ID: 2547012
    [Abstract] [Full Text] [Related]

  • 17. Improved event-related potential signs of selective attention after the administration of the cholecystokinin analog ceruletide in healthy persons.
    Schreiber H, Stolz-Born G, Pietrowsky R, Kornhuber HH, Fehm HL, Born J.
    Biol Psychiatry; 1995 May 15; 37(10):702-12. PubMed ID: 7640325
    [Abstract] [Full Text] [Related]

  • 18. Towards the therapeutic use of intranasal neuropeptide administration in metabolic and cognitive disorders.
    Hallschmid M, Benedict C, Schultes B, Perras B, Fehm HL, Kern W, Born J.
    Regul Pept; 2008 Aug 07; 149(1-3):79-83. PubMed ID: 18442862
    [Abstract] [Full Text] [Related]

  • 19. Enhanced selective attention after low-dose administration of the benzodiazepine antagonist flumazenil.
    Smolnik R, Pietrowsky R, Fehm HL, Born J.
    J Clin Psychopharmacol; 1998 Jun 07; 18(3):241-7. PubMed ID: 9617984
    [Abstract] [Full Text] [Related]

  • 20. MSH/ACTH 4-10 influences behavioral and physiological measures of attention.
    Sandman CA, George J, McCanne TR, Nolan JD, Kaswan J, Kastin AJ.
    J Clin Endocrinol Metab; 1977 May 07; 44(5):884-91. PubMed ID: 192754
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.